Carbapenem-resistant Enterobacteriaceae represent a serious therapeutic threat due to their high multi-resistance. Although still rare in Switzerland, rapid spread of carbapenemase producing Enterobacteriaceae (CPE) has been observed worldwide. Therefore the Swiss government introduced the obligation to declare on 1.1.2017. The interactive graph below depicts the actual situation in Switzerland. It is updated regularly with the data from the Federal Office of Public Health.